BIOMAT Database Logo BIOMAT Database Logo

Inhibition of carrageenin-induced rat paw oedema by crotapotin, a polypeptide complexed with phospholipase A2. 1995

E C Landucci, and E Antunes, and J L Donato, and R Faro, and S Hyslop, and S Marangoni, and B Oliveira, and G Cirino, and G de Nucci
Department of Biochemistry, UNICAMP, Campinas (SP), Brazil.

1. The effect of purified crotapotin, a non-toxic non-enzymatic chaperon protein normally complexed to a phospholipase A2 (PLA2) in South America rattlesnake venom, was studied in the acute inflammatory response induced by carrageenin (1 mg/paw), compound 48/80 (3 micrograms/paw) and 5-hydroxytryptamine (5-HT) (3 micrograms/paw) in the rat hind-paw. The effects of crotapotin on platelet aggregation, mast cell degranulation and eicosanoid release from guinea-pig isolated lung were also investigated. 2. Subplantar co-injection of crotapotin (1 and 10 micrograms/paw) with carrageenin or injection of crotapotin (10 micrograms/paw) into the contralateral paw significantly inhibited the carrageenin-induced oedema. This inhibition was also observed when crotapotin (10-30 micrograms/paw) was administered either intraperitoneally or orally. Subplantar injection of heated crotapotin (15 min at 60 degrees C) failed to inhibit carrageenin-induced oedema. Subplantar injection of crotapotin (10 micrograms/paw) also significantly inhibited the rat paw oedema induced by compound 48/80, but it did not affect 5-HT-induced oedema. 3. In adrenalectomized animals, subplantar injection of crotapotin markedly inhibited the oedema induced by carrageenin. The inhibitory effect of crotapotin was also observed in rats depleted of histamine and 5-HT stores. 4. Crotapotin (30 micrograms/paw) had no effect on either the histamine release induced by compound 48/80 in vitro or on the platelet aggregation induced by both arachidonic acid (1 nM) and platelet activating factor (1 microM) in human platelet-rich plasma. The platelet aggregation and thromboxane B2 (TXB2) release induced by thrombin (100 mu ml-1) in washed human platelets were also not affected by crotapotin. In addition, crotapotin (10 microg/paw) did not affect the release of 6-oxo-prostaglandin Fla, and TXB2 induced by ovalbumin in sensitized guinea-pig isolated lungs.5. Our results indicate that the anti-inflammatory activity of crotapotin is not due to endogenous corticosteroid release or inhibition of cyclo-oxygenase activity. It is possible that crotapotin may interact with extracellular PLA2 generated during the inflammatory process thereby reducing its hydrolytic activity.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008297 Male Males
D008407 Mast Cells Granulated cells that are found in almost all tissues, most abundantly in the skin and the gastrointestinal tract. Like the BASOPHILS, mast cells contain large amounts of HISTAMINE and HEPARIN. Unlike basophils, mast cells normally remain in the tissues and do not circulate in the blood. Mast cells, derived from the bone marrow stem cells, are regulated by the STEM CELL FACTOR. Basophils, Tissue,Basophil, Tissue,Cell, Mast,Cells, Mast,Mast Cell,Tissue Basophil,Tissue Basophils
D010741 Phospholipases A Phospholipases that hydrolyze one of the acyl groups of phosphoglycerides or glycerophosphatidates.
D010972 Platelet Activating Factor A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. AGEPC,Acetyl Glyceryl Ether Phosphorylcholine,PAF-Acether,Phosphorylcholine, Acetyl Glyceryl Ether,1-Alkyl-2-acetyl-sn-glycerophosphocholine,Platelet Aggregating Factor,Platelet Aggregation Enhancing Factor,Platelet-Activating Substance,Thrombocyte Aggregating Activity,1 Alkyl 2 acetyl sn glycerophosphocholine,Aggregating Factor, Platelet,Factor, Platelet Activating,PAF Acether,Platelet Activating Substance
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D002351 Carrageenan A water-soluble extractive mixture of sulfated polysaccharides from RED ALGAE. Chief sources are the Irish moss CHONDRUS CRISPUS (Carrageen), and Gigartina stellata. It is used as a stabilizer, for suspending COCOA in chocolate manufacture, and to clarify BEVERAGES. Carrageenin,iota-Carrageenan,kappa-Carrageenan,lambda-Carrageenan,iota Carrageenan,kappa Carrageenan,lambda Carrageenan
D003189 p-Methoxy-N-methylphenethylamine A potent mast cell degranulator. It is involved in histamine release. Agent 48-80,BW 48-80,Compound 48-80,Preparation 48-80,Agent 48 80,Agent 4880,BW 48 80,BW 4880,Compound 48 80,Compound 4880,Preparation 48 80,Preparation 4880,p Methoxy N methylphenethylamine
D003439 Crotoxin A specific complex of toxic proteins from the venom of Crotalus durissus terrificus (South American rattlesnake). It can be separated into a phospholipase A and crotapotin fragment; the latter consists of three different amino acid chains, potentiates the enzyme, and is specifically neurotoxic. Crotapotin,Crotoxin A,Crotoxin B
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal

Related Publications

E C Landucci, and E Antunes, and J L Donato, and R Faro, and S Hyslop, and S Marangoni, and B Oliveira, and G Cirino, and G de Nucci
A study of phospholipase A2-induced oedema in rat paw.
August 1989, European journal of pharmacology,
E C Landucci, and E Antunes, and J L Donato, and R Faro, and S Hyslop, and S Marangoni, and B Oliveira, and G Cirino, and G de Nucci
Inhibition of carrageenin-induced rat paw oedema by catecholamines and amine-depleting drugs.
January 1973, Acta pharmacologica et toxicologica,
E C Landucci, and E Antunes, and J L Donato, and R Faro, and S Hyslop, and S Marangoni, and B Oliveira, and G Cirino, and G de Nucci
Inhibition of carrageenin-induced rat paw oedema by substances causing a reduction of kininogen and prekallikrein in plasma.
January 1971, Acta pharmacologica et toxicologica,
E C Landucci, and E Antunes, and J L Donato, and R Faro, and S Hyslop, and S Marangoni, and B Oliveira, and G Cirino, and G de Nucci
Differential effects of Mandevilla velutina compounds on paw oedema induced by phospholipase A2 and phospholipase C.
October 1993, European journal of pharmacology,
E C Landucci, and E Antunes, and J L Donato, and R Faro, and S Hyslop, and S Marangoni, and B Oliveira, and G Cirino, and G de Nucci
Platelets and mediators in the carrageenin rat paw oedema.
January 1977, Agents and actions. Supplements,
E C Landucci, and E Antunes, and J L Donato, and R Faro, and S Hyslop, and S Marangoni, and B Oliveira, and G Cirino, and G de Nucci
Antiinflammatory activity of extracts of Biophytum sensitivum in carrageenin-induced rat paw oedema.
February 1999, Phytotherapy research : PTR,
E C Landucci, and E Antunes, and J L Donato, and R Faro, and S Hyslop, and S Marangoni, and B Oliveira, and G Cirino, and G de Nucci
EFFECT OF VARIOUS DRUGS ON CARRAGEENIN-INDUCED OEDEMA IN THE RAT HIND PAW.
December 1964, The Journal of pharmacy and pharmacology,
E C Landucci, and E Antunes, and J L Donato, and R Faro, and S Hyslop, and S Marangoni, and B Oliveira, and G Cirino, and G de Nucci
Hydrogen sulphide induces mouse paw oedema through activation of phospholipase A2.
December 2010, British journal of pharmacology,
E C Landucci, and E Antunes, and J L Donato, and R Faro, and S Hyslop, and S Marangoni, and B Oliveira, and G Cirino, and G de Nucci
Endogenous nitric oxide increases prostaglandin biosynthesis in carrageenin rat paw oedema.
November 1995, European journal of pharmacology,
E C Landucci, and E Antunes, and J L Donato, and R Faro, and S Hyslop, and S Marangoni, and B Oliveira, and G Cirino, and G de Nucci
Relationship between oedema and plasma exudation in rat paw carrageenin inflammation.
December 1978, Agents and actions,
Copied contents to your clipboard!